Clove essential oil against Staphylococcus: what a laboratory study shows

The main result is that the essential oil limited the growth of staphylococci under controlled conditions. The minimum inhibitory concentration, which is the lowest concentration that prevents visible growth, and the minimum bactericidal concentration, which is the concentration associated with killing bacteria in the test, ranged between 0.316 and 1.266 mg/mL. Activity therefore varied among the isolates. In chemical assays, the oil showed TAC and FRAP activity, tests that estimate the ability to reduce or neutralize oxidizing reagents outside of cells. The aqueous extract showed DPPH activity and activity against nitric oxide. Finally, the low hemolysis observed indicates that, in the red blood cell model, the oil did not cause marked cell rupture under the experimental conditions tested.

The research is useful because it avoids treating cloves as a uniform material. It shows that essential oil and extracts contain different fractions and can yield different results. Eugenol may contribute to the oil's biological profile, but the product is a mixture of molecules, and the study does not prove that a single component explains every effect. The greatest relevance concerns microbiological research: clinical isolates include bacteria with varying sensitivity, so the data is more informative than a test performed on a standard strain alone. However, it remains an initial step in the chain of evidence: inhibition in a test tube does not indicate that the oil reaches an infection in the body at effective and tolerable concentrations.

The study is experimental and conducted outside of a living organism. Therefore, it does not measure healing, symptom reduction, infection prevention, or safety in humans. The antioxidant tests describe chemical reactions and are not equivalent to demonstrating a reduction of oxidative stress in tissues. Similarly, low red blood cell hemolysis does not rule out effects on the skin, mucous membranes, liver, endothelium, or other cell types. Data on absorption, distribution, metabolism, elimination, or safe dosages are not available in the paper. Furthermore, antibacterial activity depends on the composition of the oil, which can vary based on botanical origin, harvesting, storage, and extraction. The data do not justify the independent use of the essential oil to treat infections.

Initial confirmation of the chemical and microbiological narrative comes from Xu and colleagues, who analyzed clove bud oil in a test tube, identifying 22 components, with eugenol accounting for 76.23%. Against Staphylococcus aureus ATCC 25923, a reference strain, the minimum inhibitory concentration was 0.625 mg/mL. The authors also observed membrane alterations and the loss of intracellular components: a process consistent with damage to the bacterial cell [1]. This confirmation is direct regarding activity and composition, but remains limited to a single strain and in vitro tests.

Li and colleagues expanded on this line of research by studying S. aureus in culture and within a food matrix. The oil damaged the bacterial cells, increased the leakage of intracellular material, and reduced by 31.23% the metabolic activity linked to the Krebs cycle, a pathway that helps the bacterium derive energy. It also reduced the expression of virulence genes and limited the bacterium in pork for seven days [2]. This is an indirect mechanistic confirmation of the antibacterial action, not a clinical demonstration.

A third study separated eugenol, unmodified oil, and acetylated derivatives. In the test tube, eugenol was the main constituent of the oil, at 70.14%, and against S. aureus, it showed a minimum inhibitory concentration of 0.58 mg/mL [3]. The result supports the possible contribution of eugenol, but it does not prove that it acts alone within the oil, nor that the data is transferable to human infections.

The most cautious aspect concerns biocompatibility. Prashar and colleagues exposed cultured human skin cells, including fibroblasts and endothelial cells, to clove oil and its components. The oil proved to be highly cytotoxic at just 0.03% volume/volume after one hour; the authors attributed up to 73% of the effect to eugenol [4]. This does not directly contradict the low hemolysis observed by Boughroud and colleagues, because red blood cells and skin cells respond differently. However, it shows that a single cell test does not define overall safety.

A second signal of caution comes from a study in mice: after intraperitoneal administration of eugenol, doses of 400 and 600 mg/kg increased micronuclei in the bone marrow, an indicator of chromosomal damage [5]. The animal model, the route of exposure, and the doses do not correspond to the dietary use of the spice or the red blood cell test. Nevertheless, the research reinforces the idea that effects may depend on dose, formulation, and tissue. No directly conflicting evidence sufficiently relevant to anti-staphylococcal activity has been identified; this does not prove the absence of contrary results.